Home LiteratureArticle Details
PMID: 12235213 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.

The Journal of experimental medicine ·Vol. 196 ·No. 6 ·2002-09-16 ·Pages 805-16

Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH

Abstract

Cytomegaloviruses (CMVs) deploy a set of genes for interference with antigen presentation in the major histocompatibility complex (MHC) class I pathway. In murine CMV (MCMV), three genes were identified so far: m04/gp34, m06/gp48, and m152/gp40. While their function as immunoevasins was originally defined after their selective expression, this may not necessarily reflect their biological role during infection. The three immunoevasins might act synergistically, but they might also compete for their common substrate, the MHC class I complexes. To approach this question in a systematic manner, we have generated a complete set of mutant viruses with deletions of the three genes in all seven possible combinations. Surface expression of a set of MHC class I molecules specified by haplotypes H-2(d) (K(d), D(d), and L(d)) and H-2(b) (K(b) and D(b)) was the parameter for evaluation of the interference with class I trafficking. The data show the following: first, there exists no additional MCMV gene of major influence on MHC class I surface expression; second, the strength of the inhibitory effect of immunoevasins shows an allele-specific hierarchy; and third, the immunoevasins act not only synergistically but can, in certain combinations, interact antagonistically. In essence, this work highlights the importance of studying the immunosubversive mechanisms of cytomegaloviruses in the context of gene expression during the viral replicative cycle in infected cells.

MeSH Terms
Alleles Animals Carrier Proteins/physiology Escherichia coli/genetics Fibroblasts/virology Genes, MHC Class I Glycoproteins/physiology Membrane Glycoproteins/physiology Mice Mice, Inbred BALB C Muromegalovirus/genetics,immunology,physiology Polymerase Chain Reaction Viral Proteins Virus Replication
Chemicals
Carrier Proteins Glycoproteins Membrane Glycoproteins Viral Proteins gp34 protein, cytomegalovirus m152 protein, cytomegalovirus
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wagner Markus
Max von Pettenkofer Institute, Department for Virology, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
Gutermann Anja
Podlech Jürgen
Reddehase Matthias J
Koszinowski Ulrich H
References (54)
54 references, click to expand
  1. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo.
    J Exp Med. 1999 Nov 1;190(9):1285-96 PMID: 10544200
  2. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.
    Nat Immunol. 2002 Jun;3(6):529-35 PMID: 12021778
  3. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules.
    EMBO J. 2000 Mar 1;19(5):870-81 PMID: 10698929
  4. Forward with BACs: new tools for herpesvirus genomics.
    Trends Genet. 2000 Jun;16(6):254-9 PMID: 10827452
  5. Viral subversion of the immune system.
    Annu Rev Immunol. 2000;18:861-926 PMID: 10837078
  6. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.
    J Virol. 2000 Sep;74(17):7720-9 PMID: 10933677
  7. Viral mechanisms of immune evasion.
    Trends Microbiol. 2000 Sep;8(9):410-8 PMID: 10989308
  8. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
    J Virol. 2000 Nov;74(22):10729-36 PMID: 11044117
  9. Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli.
    Mol Genet Metab. 2001 Jan;72(1):15-26 PMID: 11161824
  10. Techniques: Recombinogenic engineering--new options for cloning and manipulating DNA.
    Trends Biochem Sci. 2001 May;26(5):325-31 PMID: 11343926
  11. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment.
    J Immunol. 2001 Oct 1;167(7):3894-902 PMID: 11564807
  12. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.
    J Exp Med. 2001 Oct 1;194(7):967-78 PMID: 11581318
  13. Herpesvirus genetics has come of age.
    Trends Microbiol. 2002 Jul;10(7):318-24 PMID: 12110210
  14. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance.
    Nat Rev Immunol. 2002 Nov;2(11):831-44 PMID: 12415307
  15. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens.
    Nature. 1976 May 27;261(5558):312-4 PMID: 179019
  16. Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice.
    Immunol Rev. 1979;47:175-206 PMID: 398326
  17. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted.
    Nature. 1981 Aug 6;292(5823):547-9 PMID: 6166872
  18. Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli.
    J Bacteriol. 1983 Mar;153(3):1424-31 PMID: 6402497
  19. Molecular cloning and physical mapping of murine cytomegalovirus DNA.
    J Virol. 1983 Sep;47(3):421-33 PMID: 6312075
  20. Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus.
    J Virol. 1985 May;54(2):422-8 PMID: 2985805
  21. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.
    J Virol. 1985 Aug;55(2):264-73 PMID: 2991554
  22. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
    Curr Top Microbiol Immunol. 1990;154:125-69 PMID: 2161319
  23. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.
    Cell. 1991 Sep 20;66(6):1145-53 PMID: 1913805
  24. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.
    J Virol. 1992 Jul;66(7):4399-406 PMID: 1318410
  25. Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.
    J Virol. 1995 Jan;69(1):231-8 PMID: 7983714
  26. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant.
    Gene. 1995 May 26;158(1):9-14 PMID: 7789817
  27. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.
    Cell. 1996 Mar 8;84(5):769-79 PMID: 8625414
  28. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
    Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10990-5 PMID: 8855296
  29. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11327-33 PMID: 8876135
  30. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.
    Nature. 1996 Dec 5;384(6608):432-8 PMID: 8945469
  31. Analysis of the complete DNA sequence of murine cytomegalovirus.
    J Virol. 1996 Dec;70(12):8833-49 PMID: 8971012
  32. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.
    EMBO J. 1997 Feb 17;16(4):685-94 PMID: 9049298
  33. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments.
    Immunity. 1997 Jan;6(1):57-66 PMID: 9052837
  34. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs.
    J Virol. 1997 Apr;71(4):2980-7 PMID: 9060657
  35. Recombinant cytomegaloviruses for study of replication and pathogenesis.
    Intervirology. 1996;39(5-6):320-30 PMID: 9130042
  36. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
    Immunity. 1997 May;6(5):613-21 PMID: 9175839
  37. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.
    Immunity. 1997 May;6(5):623-32 PMID: 9175840
  38. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.
    Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6904-9 PMID: 9192664
  39. Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome.
    J Bacteriol. 1997 Jul;179(13):4426-8 PMID: 9209066
  40. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.
    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14759-63 PMID: 9405686
  41. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation.
    J Gen Virol. 1998 Sep;79 ( Pt 9):2099-104 PMID: 9747717
  42. A new logic for DNA engineering using recombination in Escherichia coli.
    Nat Genet. 1998 Oct;20(2):123-8 PMID: 9771703
  43. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.
    EMBO J. 1999 Feb 15;18(4):1081-91 PMID: 10022849
  44. Rapid modification of bacterial artificial chromosomes by ET-recombination.
    Nucleic Acids Res. 1999 Mar 15;27(6):1555-7 PMID: 10037821
  45. In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus.
    J Virol. 1999 Jun;73(6):5043-55 PMID: 10233967
  46. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.
    J Virol. 1999 Jul;73(7):5970-80 PMID: 10364349
  47. Cytomegaloviral control of MHC class I function in the mouse.
    Immunol Rev. 1999 Apr;168:167-76 PMID: 10399073
  48. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.
    J Virol. 1999 Aug;73(8):7056-60 PMID: 10400809
  49. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.
    J Virol. 1999 Oct;73(10):8320-9 PMID: 10482582
  50. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus.
    J Virol. 1994 Oct;68(10):6243-53 PMID: 8083964
  51. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis.
    Nat Immunol. 2001 Nov;2(11):1077-84 PMID: 11668340
  52. The glycoprotein gp48 of murine cytomegalovirusL proteasome-dependent cytosolic dislocation and degradation.
    J Biol Chem. 2002 Jan 18;277(3):2216-24 PMID: 11707434
  53. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.
    J Virol. 2002 Mar;76(5):2316-28 PMID: 11836410
  54. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
    J Virol. 2000 Feb;74(4):1871-84 PMID: 10644360
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2002-09-16
Pages
805-16
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2194048
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]